Kymera Therapeutics Inc - KYMR - stock price prediction, stock price target, analyst ratings from 22 analysts

Kymera Therapeutics Inc has a share price target of US$ 119, revenue growth forecast of 1.0%, and profit growth estimate of -13.3% for FY26, based on top 22 analyst calls.